Fermi Inc. (FRMI) Stock News Today: $150M Funding Deal Terminated, Project Matador Updates, and Analyst Price Targets (Dec. 14, 2025)

Fermi Inc. (FRMI) Stock News Today: $150M Funding Deal Terminated, Project Matador Updates, and Analyst Price Targets (Dec. 14, 2025)

December 14, 2025 — Fermi Inc. (NASDAQ: FRMI, LSE: FRMI) is in the spotlight after a dramatic selloff tied to a sudden change in its earliest tenant and financing narrative for Project Matador, the company’s flagship “behind-the-meter” power-and-data campus planned for West Texas. The drop has intensified debate over whether FRMI is a long-term AI-infrastructure winner trading at a steep discount—or a pre-revenue execution story facing its first major stress test. As of the most recent quote available heading into Sunday (markets closed), FRMI traded around $10.09 after a volatile week that included a heavy-volume plunge and a wide intraday
RH Stock News & Forecast (NYSE:RH) on Dec. 14, 2025: Q3 FY2025 Earnings, Guidance Reset, and New Analyst Price Targets

RH Stock News & Forecast (NYSE:RH) on Dec. 14, 2025: Q3 FY2025 Earnings, Guidance Reset, and New Analyst Price Targets

Published: Sunday, December 14, 2025 (U.S. markets last closed Friday, Dec. 12) RH (NYSE:RH)—the luxury home furnishings and lifestyle retailer—heads into the new week with investors digesting a busy stretch of catalysts: a fresh quarterly report, updated full‑year outlook, and a wave of analyst target changes that reshaped the near‑term narrative around tariffs, margin pressure, and a still‑sluggish housing backdrop. Reuters+1 On Friday, RH shares closed at $162.01, up roughly 5.7% on the day after the company’s results and outlook reset hit the tape late Thursday. StockAnalysis RH stock today: what changed heading into Dec. 14, 2025? The immediate catalyst
CCC Intelligent Solutions Holdings Inc. Stock (NASDAQ: CCC): $500M Buyback, Debt-Funded ASR, Analyst Price Targets, and What’s Next (Dec. 14, 2025)

CCC Intelligent Solutions Holdings Inc. Stock (NASDAQ: CCC): $500M Buyback, Debt-Funded ASR, Analyst Price Targets, and What’s Next (Dec. 14, 2025)

CCC Intelligent Solutions Holdings Inc. shares are in focus this weekend after the company unveiled a major capital-return move that instantly reshaped the near‑term narrative around the stock: a fresh $500 million share repurchase authorization, anchored by a $300 million accelerated share repurchase (ASR) funded with new term-loan borrowings. SEC+1 Below is a detailed look at what’s new on Dec. 14, 2025, what Wall Street forecasts currently imply for upside/downside, and the operational and balance‑sheet factors investors are watching heading into the next earnings cycle. CCC stock today: price, range, and ticker clarity (CCC vs. “CCCS”) Because many headlines and
Immunovant (IMVT) Stock News and Forecast for Dec. 14, 2025: $550M Financing Closes, Roivant Buys $350M, Analysts Update Targets

Immunovant (IMVT) Stock News and Forecast for Dec. 14, 2025: $550M Financing Closes, Roivant Buys $350M, Analysts Update Targets

Immunovant, Inc. (NASDAQ: IMVT) stock is closing out the week in focus after the company completed a major equity raise designed to bolster funding for its autoimmune pipeline—while its controlling shareholder, Roivant Sciences, stepped in as the largest buyer. As of the most recent market close ahead of Sunday, December 14, 2025, IMVT shares were around $26.42, up about 6.6% on the day, following heightened volatility and elevated trading activity during the week. Below is what changed, why it matters for investors tracking Immunovant stock, and how Wall Street-style consensus forecasts currently frame upside vs. risk. What’s driving Immunovant stock
Amicus Therapeutics (FOLD) Stock News, Forecasts and Analyst Outlook on Dec. 14, 2025: What’s Driving the Rally?

Amicus Therapeutics (FOLD) Stock News, Forecasts and Analyst Outlook on Dec. 14, 2025: What’s Driving the Rally?

Amicus Therapeutics (NASDAQ: FOLD) is near a 52-week high after strong results and bullish analyst coverage. Here’s the latest news, forecasts, catalysts, and key risks as of Dec. 14, 2025. As of Sunday, December 14, 2025 (with U.S. markets closed), Amicus Therapeutics, Inc. (NASDAQ: FOLD) is finishing the week in the spotlight after a sharp move higher. The stock last traded around $10.55 on Friday, December 12, after climbing roughly 6.6% on the session and touching an intraday high of $10.85—a level that also marks the top end of its $5.51–$10.85 52‑week range. Yahoo Finance The late-week push has also
lululemon athletica (LULU) Stock News Today (Dec. 14, 2025): CEO Transition, Q3 Beat, Buyback Boost, and Nasdaq-100 Exit in Focus

lululemon athletica (LULU) Stock News Today (Dec. 14, 2025): CEO Transition, Q3 Beat, Buyback Boost, and Nasdaq-100 Exit in Focus

Lululemon (NASDAQ: LULU) stock is back in the spotlight after a Q3 earnings beat, updated fiscal 2025 guidance, a $1.0B buyback authorization increase, a CEO succession announcement, and confirmation it will be removed from the Nasdaq-100. Here’s what investors are watching as of December 14, 2025. lululemon athletica inc. stock (NASDAQ: LULU) has become one of the most talked-about retail names heading into the final stretch of 2025. The story is no longer just about athleisure demand—it’s about a leadership reset, a turnaround effort in the Americas, and index-related catalysts that could influence trading flows before year-end. Because December 14,
EverCommerce (EVCM) Stock News, Analyst Forecasts, and Key Catalysts as of Dec. 14, 2025

EverCommerce (EVCM) Stock News, Analyst Forecasts, and Key Catalysts as of Dec. 14, 2025

Updated: December 14, 2025 EverCommerce Inc. (NASDAQ: EVCM) is back on many investors’ radar after a sharp rebound in December that pushed the stock near its 52‑week high—despite Wall Street remaining split on the company’s near‑term upside. As of December 14, 2025 (a Sunday, when U.S. markets are closed), EVCM last traded at $12.08 after Friday’s session (December 12), a move that capped a notable two‑week surge. StockAnalysis At the same time, the latest “instant alert” coverage dated December 14, 2025 highlights a “Hold” consensus from analysts, continued insider selling activity, and a wide dispersion in price targets—signals that the
Rivian Stock (RIVN) News, Forecasts and Analysis on Dec. 14, 2025: Autonomy & AI Day, Analyst Upgrades, and What Investors Should Watch Next

Rivian Stock (RIVN) News, Forecasts and Analysis on Dec. 14, 2025: Autonomy & AI Day, Analyst Upgrades, and What Investors Should Watch Next

Rivian Automotive, Inc. (NASDAQ: RIVN) is ending the week at the center of one of the EV market’s biggest storylines: a sharp stock swing tied to its first Autonomy & AI Day, new in-house self-driving silicon, and a push toward subscription software revenue. As of Sunday, December 14, 2025 (with U.S. markets closed for the weekend), Rivian shares last closed Friday, Dec. 12 at about $18.42, up roughly 12% on the day after a volatile two-session reaction to the company’s autonomy announcements. MarketBeat+2StockAnalysis+2 Below is a detailed, publication-ready breakdown of today’s Rivian stock news, the latest Wall Street forecasts, and
Clear Secure (YOU) Stock News on Dec. 14, 2025: CMS Medicare.gov Deal, JPMorgan Upgrade, Insider-Sale Filing, and Updated Price Targets

Clear Secure (YOU) Stock News on Dec. 14, 2025: CMS Medicare.gov Deal, JPMorgan Upgrade, Insider-Sale Filing, and Updated Price Targets

As of Sunday, December 14, 2025, Clear Secure, Inc. (NYSE: YOU) is one of the most talked-about mid-cap “digital identity” names after a sharp rally that pushed the stock to fresh multi-year highs in the last trading session. The move has been fueled by a major U.S. government-related healthcare contract, a bullish JPMorgan analyst upgrade, and renewed debate about whether Clear is transitioning from a travel-adjacent membership business into a broader, reusable identity platform for highly regulated industries. Clear Secure, Inc. Below is a complete, publication-ready rundown of the latest Clear Secure stock news, forecasts, and analyses available as of
Polestar Stock (PSNY) News on Dec. 14, 2025: Reverse Split Aftermath, Nasdaq Compliance Push, and the Latest Forecasts

Polestar Stock (PSNY) News on Dec. 14, 2025: Reverse Split Aftermath, Nasdaq Compliance Push, and the Latest Forecasts

Updated: Sunday, December 14, 2025Polestar Automotive Holding UK PLC’s U.S.-listed stock (Nasdaq: PSNY) is drawing fresh attention this weekend after a 1-for-30 reverse split–style ADS ratio change took effect earlier this week, reshaping the share count and headline price but not the company’s underlying challenges: cash burn, tariffs, and a race to stabilize margins while scaling deliveries. Business Wire+2NASDAQ Trader+2 Key takeaways for Polestar investors today What happened to Polestar stock this week Because U.S. markets are closed on Sunday, December 14, the latest “as-of” snapshot reflects Friday’s trading (Dec. 12) and the volatile sessions that followed the corporate action
Greater Victoria Tourism Won’t Chase FIFA World Cup 2026 “Overflow Dollars,” Destination CEO Says — Victoria, BC News (Dec. 14, 2025)

Greater Victoria Tourism Won’t Chase FIFA World Cup 2026 “Overflow Dollars,” Destination CEO Says — Victoria, BC News (Dec. 14, 2025)

VICTORIA, B.C. — December 14, 2025 — With Vancouver accelerating preparations for the FIFA World Cup 2026, tourism leaders in Greater Victoria are taking a notably cautious stance: don’t expect a spending windfall on Vancouver Island just because the world will be watching matches across the Salish Sea. A report published by the Victoria Times Colonist says Destination Greater Victoria—the region’s destination marketing organization—“won’t be chasing FIFA overflow dollars.” The organization’s CEO, Paul Nursey, told the newspaper that Vancouver’s role as a World Cup host city is unlikely to yield significant benefits on the Island, signaling a strategy focused on
14 December 2025
Pfizer Stock (PFE) News and Forecast for Dec. 14, 2025: Dividend, Obesity Deal, Oncology Catalysts, and What Analysts Expect Next

Pfizer Stock (PFE) News and Forecast for Dec. 14, 2025: Dividend, Obesity Deal, Oncology Catalysts, and What Analysts Expect Next

Updated: Sunday, December 14, 2025 (U.S. markets last closed Friday, Dec. 12) Pfizer Inc. (NYSE: PFE) is ending the week in a familiar spot—trading in the mid‑$20s—while investors weigh a high dividend payout against a fast-moving set of catalysts: new oncology data from the Seagen portfolio, a fresh attempt at an oral obesity drug, ongoing cost-cutting, and a looming shift in the U.S. COVID vaccine policy backdrop. Reuters+3StockAnalysis+3Reuters+3 Below is a detailed roundup of the most important Pfizer stock headlines, forecasts, and analyst takes available as of Dec. 14, 2025, plus what to watch next heading into Pfizer’s scheduled 2026

Stock Market Today

Walmart stock jumps to $131 as traders brace for CPI and Feb. 19 earnings

Walmart stock jumps to $131 as traders brace for CPI and Feb. 19 earnings

7 February 2026
Walmart shares rose 3.3% Friday to $131.18, up 10% since Jan. 30, as the Dow closed above 50,000 for the first time. The retailer’s market value crossed $1 trillion this week. Investors await January inflation data on Feb. 13 and Walmart’s quarterly results on Feb. 19 for signs of continued momentum.
Caterpillar stock price jumps 7% to $726 as Dow cracks 50,000 — what matters next week

Caterpillar stock price jumps 7% to $726 as Dow cracks 50,000 — what matters next week

7 February 2026
Caterpillar shares surged 7.1% to $726.20 Friday, driving the Dow above 50,000 for the first time. The move erased recent losses and followed insider selling by Group President Bob De Lange earlier in the week. Deere and CNH Industrial also gained as investors rotated into industrial stocks. Markets await next week’s U.S. jobs and inflation data.
Amazon stock slides as $200B AI spending plan meets cautious profit outlook

Amazon stock slides as $200B AI spending plan meets cautious profit outlook

7 February 2026
Amazon shares fell 9% Friday after the company announced plans for $200 billion in 2026 capital spending, mainly for AWS and AI, and issued a first-quarter profit outlook below estimates. The stock drop could erase $200 billion in market value. Fourth-quarter net sales rose 14% to $213.4 billion, while free cash flow declined due to higher spending on AI infrastructure.
Go toTop